Actively Recruiting
Study on the Mechanism of Yifei Moxibustion Improving Immune Function in COPD Based on Plasma Exosome miRNAs
Led by Henan University of Traditional Chinese Medicine · Updated on 2025-08-19
120
Participants Needed
1
Research Sites
68 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study adopted a randomized controlled design, enrolling 90 patients and 30 healthy volunteers. The patients were randomly divided into the Yifei Moxibustion group, the conventional Western medicine treatment group, and the TCM syndrome differentiation treatment group, and were treated for 3 months. Peripheral venous blood was collected from both the healthy volunteers and the patients to observe indicators such as T cell subsets and immunoglobulins, to evaluate the effect of Yifei Moxibustion on improving immune function. The regulation of target genes by exosomes and potential action targets and molecular mechanisms were preliminarily verified through techniques such as nanoparticle tracking technology and flow cytometry.
CONDITIONS
Official Title
Study on the Mechanism of Yifei Moxibustion Improving Immune Function in COPD Based on Plasma Exosome miRNAs
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients who meet the diagnostic criteria for stable chronic obstructive pulmonary disease
- Patients who meet the traditional Chinese medicine diagnostic criteria for lung qi deficiency, lung-spleen qi deficiency, or lung-kidney qi deficiency
- Aged 18 to 80 years old
- Voluntarily signed the informed consent form
You will not qualify if you...
- Pregnant or lactating women
- Patients with cognitive impairment, confusion, dementia, or mental disorders
- Patients with unstable angina pectoris or acute myocardial infarction
- Patients with a history of syncope after exercise or bone and joint diseases affecting exercise
- Patients with pneumothorax, pleural effusion, pulmonary embolism, or tumors
- Patients known to be allergic to ingredients of the moxibustion powder
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
the First Affiliated Hospital of Henan University of Chinese Medicine
Zhengzhou, Henan, China, 450056
Actively Recruiting
Research Team
Y
Yang Xie, Doctor
CONTACT
Y
Yanmin Shi, Master
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here